Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now lists a broader set of study locations across multiple countries and regions, expanding the geographic coverage of sites. Some locations have been reorganized or removed.
    Difference
    3%
    Check dated 2025-12-19T10:32:37.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a new revision label 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T02:07:09.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added new study locations (Seoul, Central Singapore, North Holland, Central Jutland) and site details (e.g., Pittsburgh PA; Aarhus N; Berlin; Amsterdam; Poznan; Songpa-gu), bringing the total locations to 204. Updated follow-up time frame to from randomization to death up to approximately 60 months.
    Difference
    0.9%
    Check dated 2025-11-21T00:44:31.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The Taiwan site entry was changed from 'Tainan City, Taiwan, 70403' to 'Tainan, Taiwan, 70403'.
    Difference
    0.1%
    Check dated 2025-11-13T21:42:01.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page; the study details, eligibility criteria, and locations appear unchanged.
    Difference
    0.1%
    Check dated 2025-10-30T12:08:00.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The page now adds a verified date with a status of Active, not recruiting and includes an Unknown status, while removing the prior explicit 'Active, not recruiting' line. This alters how recruitment status is communicated.
    Difference
    0.5%
    Check dated 2025-10-16T06:20:20.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.